 SHANGHAI and GAITHERSBURG, Md., Feb. 5, 2021 PRNewswire -- I-Mab Nasdaq: IMAB, a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics, today announced multiple clinical advancements for its... 